Illumina
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Non-Qualified Stock Option (right to buy) 6,000 $9.08 $54,480
Sale
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
CABOU CHRISTIAN officer: Sr VP & General Counsel
 Common Stock 10,000 $27.4 $274,000
Option
CABOU CHRISTIAN officer: Sr VP & General Counsel
 Common Stock 10,000 $27.4 $274,000
Option
CABOU CHRISTIAN officer: Sr VP & General Counsel
 Non-Qualified Stock Option (right to buy) 10,000 $27.4 $274,000
Sale
WALT DAVID R director
 Common Stock 5,000 $73.35 $366,770
Option
FLATLEY JAY T director
 Common Stock 10,000 $2.77 $27,700
Option
FLATLEY JAY T director
 Non-Qualified Stock Option (right to buy) 10,000 $2.77 $27,700
Sale
FLATLEY JAY T director
 Common Stock 10,000 $2.77 $27,700
Sale
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
WALT DAVID R director
 Common Stock 5,000 $77.88 $389,390
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Non-Qualified Stock Option (right to buy) 6,000 $9.08 $54,480
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
WALT DAVID R director
 Common Stock 5,000 $77.75 $388,770
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Sale
FLATLEY JAY T director
 Common Stock 10,000 $74.43 $744,340
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Non-Qualified Stock Option (right to buy) 5,000 $2.77 $13,850
Sale
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Non-Qualified Stock Option (right to buy) 6,000 $9.08 $54,480
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
WALT DAVID R director
 Common Stock 5,000 $74.92 $374,610
Sale
WALT DAVID R director
 Common Stock 5,000 $68.77 $343,855
Option
FLATLEY JAY T director
 Non-Qualified Stock Option (right to buy) 10,000 $2.77 $27,700
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Option
FLATLEY JAY T director
 Common Stock 10,000 $2.77 $27,700
Sale
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Sale
FLATLEY JAY T director
 Common Stock 10,000 $2.77 $27,700
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Non-Qualified Stock Option (right to buy) 5,000 $2.77 $13,850
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Non-Qualified Stock Option (right to buy) 6,000 $9.08 $54,480
Sale
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
WALT DAVID R director
 Common Stock 5,000 $64.94 $324,700
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
WALT DAVID R director
 Common Stock 5,000 $72.01 $360,070
Sale
FLATLEY JAY T director
 Common Stock 10,000 $73.96 $739,640
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Non-Qualified Stock Option (right to buy) 5,000 $2.77 $13,850
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Sale
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Sale
WALT DAVID R director
 Common Stock 5,000 $75.46 $377,290
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Non-Qualified Stock Option (right to buy) 6,000 $9.08 $54,480
Option
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
ORPIN TRISTAN officer: EVP Clinical Genomics
 Common Stock 6,000 $9.08 $54,480
Sale
WALT DAVID R director
 Common Stock 5,000 $73.39 $366,955
Sale
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Option
FLATLEY JAY T director
 Common Stock 10,000 $2.77 $27,700
Option
FLATLEY JAY T director
 Non-Qualified Stock Option (right to buy) 10,000 $2.77 $27,700
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Common Stock 5,000 $2.77 $13,850
Sale
FLATLEY JAY T director
 Common Stock 10,000 $2.77 $27,700
Option
STUELPNAGEL JOHN R director, officer: Sr VP and COO
 Non-Qualified Stock Option (right to buy) 5,000 $2.77 $13,850

Showing 2750 to 2800 of 3100 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: